ℹ️
🇬🇧
Search
Search for people relevant for "281:"
281:
Person
Class
Person
Publication
Programmes
Export current view
James D. Cavenagh
Person without affiliation with CUNI
1 publication
Publication
publication
A phase 2, randomized, double-blind, placebo-controlled study of siltuximab (anti-IL-6 mAb) and bortezomib versus bortezomib alone in patients with relapsed or refractory multiple myeloma
2015 |
First Faculty of Medicine
Loading network view...
